Antibacterial mechanisms of rhodomyrtone against important hospital-acquired antibiotic-resistant pathogenic bacteria

Journal of Medical Microbiology

Volumn 62, Issue PART1, 2013, Pages 78-85

  Leejae, Sukanlaya ^a   Taylor, Peter William ^b   Voravuthikunchai, Supayang Piyawan ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; RHODOMYRTONE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CELL MEMBRANE; CELL WALL; CONTROLLED STUDY; CYTOLYSIS; ENTEROCOCCUS FAECALIS; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROCOCCUS FAECALIS; HOSPITALS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MYRTACEAE; SELECTION, GENETIC; STAPHYLOCOCCUS AUREUS; TIME FACTORS; VANCOMYCIN RESISTANCE; XANTHONES;

EID: 84871152282     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.049205-0     Document Type: Article

References (48)

1. Alder, J. D. (2005). Daptomycin: a new drug class for the treatment of Gram-positive infections. Drugs Today (Barc) 41, 81-90.
2. Aligholi, M., Emaneini, M., Jabalameli, F., Shahsavan, S., Dabiri, H. & Sedaght, H. (2008). Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med Princ Pract 17, 432-434.
3. Bibi, Y., Nisa, S., Chaudhary, F. M. & Zia, M. (2011). Antibacterial activity of some selected medicinal plants of Pakistan. BMC Complement Altern Med 11, 52.
4. Bilal, M., Cleveland, K. O. & Gelfand, M. S. (2009). Communityacquired methicillin-resistant Staphylococcus aureus and Lemierre syndrome. Am J Med Sci 338, 326-327.
5. Bogomolova, N. S., Bol'shakov, L. V., Kuznetsova, S. M. & Oreshkina, T. D. (2011). [Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units]. Antibiot Khimioter 56, 37-45 (in Russian).
6. Brusselaers, N., Vogelaers, D. & Blot, S. (2011). The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care 1, 47.
7. Carson, C. F., Mee, B. J. & Riley, T. V. (2002). Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob Agents Chemother 46, 1914-1920.
8. Chusri, S. & Voravuthikunchai, S. P. (2011). Damage of staphylococcal cytoplasmic membrane by Quercus infectoria G. Olivier and its components. Lett Appl Microbiol 52, 565-572.
9. CLSI (2009). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, approved standard, 8th edn. Wayne, PA: Clinical and Laboratory Standards Institute.
10. Cui, L., Ma, X., Sato, K., Okuma, K., Tenover, F. C., Mamizuka, E. M., Gemmell, C. G., Kim, M. N., Ploy, M. C. & other authors (2003). Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 41, 5-14.
11. Cui, L., Iwamoto, A., Lian, J.Q., Neoh, H. M., Maruyama, T., Horikawa, Y. & Hiramatsu, K. (2006). Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 50, 428-438.
12. Cunha, B. A. (2005). Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy. Clin Microbiol Infect 11 (Suppl. 4), 33-42.
13. Dathe, M., Schümann, M., Wieprecht, T., Winkler, A., Beyermann, M., Krause, E., Matsuzaki, K., Murase, O. & Bienert, M. (1996). Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 35, 12612-12622.
14. De Kraker, M. E., Wolkewitz, M., Davey, P. G., Koller, W., Berger, J., Nagler, J., Icket, C., Kalenic, S., Horvatic, J. & other authors (2011). Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillinresistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 55, 1598-1605.
15. Geetha, K. M., Sridhar, C. & Murugan, V. (2010a). Antioxidant and gastroprotective activities of Rhodomyrtus tomentosa (Ait.) Hassk. Int J Pharmatech Res 2, 283-291.
16. Geetha, K. M., Sridhar, C. & Murugan, V. (2010b). Antioxidant and healing effect of aqueous alcoholic extract of Rhodomyrtus tomentosa (Ait.) Hassk on chronic gastric ulcers in rats. J Pharm Res 3, 2860-2862.
17. Gibbons, S. (2008). Phytochemicals for bacterial resistance-strengths, weaknesses and opportunities. Planta Med 74, 594-602.
18. Gould, I. M. (2008). The epidemiology of antibiotic resistance. Int J Antimicrob Agents 32 (Suppl. 1), S2-S9.
19. Hiranrat, A. & Mahabusarakam, W. (2008). New acylphloroglucinols from the leaves of Rhodomyrtus tomentosa. Tetrahedron 64, 11193-11197.
20. Howden, B. P., Johnson, P. D. R., Ward, P. B., Stinear, T. P. & Davies, J. K. (2006). Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 50, 3039-3047.
21. Izzo, A. A. & Ernst, E. (2009). Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 69, 1777-1798.
22. Koehn, F. E. & Carter, G. T. (2005). The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4, 206-220.
23. Kruger, W. M. A., Tanuri, M. & De Almeida, D. F. (1988). Isolation and characterization of drug-resistant mutants of Herpetomonas samuelpessoai (Kinetoplastida, Trypanosomatidae). Rev Brazil Genet 11, 237-251.
24. Liebowitz, L. D., Saunders, J., Chalkley, L. J. & Koornhof, H. J. (1988). In vitro selection of bacteria resistant to LY146032, a new cyclic lipopeptide. Antimicrob Agents Chemother 32, 24-26.
25. Lim, K. T., Yasin, R., Yeo, C. C., Puthucheary, S. & Thong, K. L. (2009). Characterization of multidrug resistant ESBL-producing Escherichia coli isolates from hospitals in Malaysia. J Biomed Biotechnol 2009, 1-10.
26. Limsuwan, S., Trip, E. N., Kouwen, T. R., Piersma, S., Hiranrat, A., Mahabusarakam, W., Voravuthikunchai, S. P., van Dijl, J. M. & Kayser, O. (2009). Rhodomyrtone: a new candidate as natural antibacterial drug from Rhodomyrtus tomentosa. Phytomedicine 16, 645-651.
27. Limsuwan, S., Hesseling-Meinders, A., Voravuthikunchai, S. P., van Dijl, J. M. & Kayser, O. (2011). Potential antibiotic and anti-infective effects of rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. on Streptococcus pyogenes as revealed by proteomics. Phytomedicine 18, 934-940.
28. Lv, J., Yin, L., Liu, T. & Wang, Y. (2007). Synthesis of pseudopeptides based L-tryptophan as a potential antimicrobial agent. Bioorg Med Chem Lett 17, 1601-1607.
29. McKay, G. A., Beaulieu, S., Arhin, F. F., Belley, A., Sarmiento, I., Parr, T., Jr & Moeck, G. (2009). Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother 63, 1191-1199.
30. Menichetti, F. (2005). Current and emerging serious Gram-positive infections. Clin Microbiol Infect 11 (Suppl. 3), 22-28.
31. Mohamed, G. A. & Ibrahim, S. R. M. (2007). Eucalyptone G, a new phloroglucinol derivative and other constituents from Eucalyptus globulus Labill. ARKIVOC 15, 281-291.
32. Moore, C. L., Lu, M., Cheema, F., Osaki-Kiyan, P., Perri, M. B., Donabedian, S., Haque, N. Z. & Zervos, M. J. (2011). Prediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection: a clinically useful risk stratification tool. Antimicrob Agents Chemother 55, 4581-4588.
33. Njume, C., Afolayan, A. J., Samie, A. & Ndip, R. N. (2011). Inhibitory and bactericidal potential of crude acetone extracts of Combretum molle (Combretaceae) on drug-resistant strains of Helicobacter pylori. J Health Popul Nutr 29, 438-445.
34. Ong, H. C. & Nordiana, M. (1999). Malay ethno-medico botany in Machang, Kelantan, Malaysia. Fitoterapia 70, 502-513.
35. Oonmetta-aree, J., Suzuki, T., Gasaluck, P. & Eumkeb, G. (2006). Antimicrobial properties and action of galangal (Alpinia galanga Linn.) on Staphylococcus aureus. LWT 39, 1214-1220.
36. Rivera, A. M. & Boucher, H. W. (2011). Current concepts in antimicrobial therapy against select Gram-positive organisms: methicillin- resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci. Mayo Clin Proc 86, 1230-1243.
37. Saising, J., Ongsakul, M. & Voravuthikunchai, S. P. (2011). Rhodomyrtus tomentosa (Aiton) Hassk. ethanol extract and rhodomyrtone: a potential strategy for the treatment of biofilm-forming staphylococci. J Med Microbiol 60, 1793-1800.
38. Salni, D., Sargent, M. V., Skelton, B. W., Soediro, I., Sutisna, M., White, A. H. & Yulinah, E. (2002). Rhodomyrtone, an antibiotic from Rhodomyrtus tomentosa. Aust J Chem 55, 229-232.
39. Sianglum, W., Srimanote, P., Wonglumsom, W., Kittiniyom, K. & Voravuthikunchai, S. P. (2011). Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate. PLoS ONE 6, 1-10.
40. Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J. & Hageman, J. C. (2008). Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 46, 668-674.
41. Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D. & other authors for the Glycopeptide-Intermediate Staphylococcus aureus Working Group (1999). Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 340, 493-501.
42. Tenney, J. H., Maack, R. W. & Chippendale, G. R. (1983). Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar. Antimicrob Agents Chemother 23, 188-189.
43. Visutthi, M., Srimanote, P. & Voravuthikunchai, S. P. (2011). Responses in the expression of extracellular proteins in methicillinresistant Staphylococcus aureus treated with rhodomyrtone. J Microbiol 49, 956-964.
44. Voravuthikunchai, S. P., Dolah, S. & Charernjiratrakul, W. (2010). Control of Bacillus cereus in foods by Rhodomyrtus tomentosa (Ait.) Hassk. Leaf extract and its purified compound. J Food Prot 73, 1907-1912.
45. Walsh, C. (2003). Where will new antibiotics come from? Nat Rev Microbiol 1, 65-70.
46. Walsh, F. M. & Amyes, S. G. B. (2004). Microbiology and drug resistance mechanisms of fully resistant pathogens. Curr Opin Microbiol 7, 439-444.
47. Wei, F. (2006a). Manufacture of oral liquid containing traditional Chinese medicine extract for treating gynecopathy [Guangxi Huahong Pharmaceutical Co., Ltd, People's Republic of China; Shanghai Fosun Pharmaceutical (Group) Co., Ltd], Faming Zhuanli Shenqing Gongkai Shuomingshu. People's Republic of China patent CN1846715.
48. Wei, F. (2006b). Manufacture of traditional Chinese medicine composition for treating urinary tract infection [Gungxi Huahong Pharmaceutical Co., Ltd, People's Republic of China; Shanghai Fosun Pharmaceutical (Group) Co., Ltd], Faming Zhuanli Shenqing Gongkai Shuomingshu. People's Republic of China patent CN1853687.